1.Study of Morphea.
Korean Journal of Dermatology 1968;6(1):25-28
No abstract available.
Scleroderma, Localized*
2.A Rare Case of Bilateral Frontal Linear Scleroderma (En Coup de Sabre)
Joo Ran HONG ; Ji Su LEE ; Yang Won LEE ; Yong Beom CHOE ; Kyu Joong AHN
Korean Journal of Dermatology 2019;57(6):346-347
No abstract available.
Scleroderma, Localized
3.Transient Bizarre Nystagmus With Frontal Linear Scleroderma With Brain Calcification.
Bek San PARK ; Hyuk Sung KWON ; Jinse PARK ; Hojin CHOI ; Kyu Yong LEE ; Young Joo LEE ; Seong Ho KOH
Journal of the Korean Neurological Association 2012;30(3):241-243
No abstract available.
Brain
;
Scleroderma, Localized
;
Scleroderma, Systemic
4.A Case of Segmental Vitiligo with Generalized Morphea Stabilized by Antimalarial Medication.
Hee Jung KIM ; Dongyun SHIN ; Sang Ho OH
Annals of Dermatology 2016;28(2):249-250
No abstract available.
Scleroderma, Localized*
;
Vitiligo*
5.A Case of Segmental Vitiligo with Generalized Morphea Stabilized by Antimalarial Medication.
Hee Jung KIM ; Dongyun SHIN ; Sang Ho OH
Annals of Dermatology 2016;28(2):249-250
No abstract available.
Scleroderma, Localized*
;
Vitiligo*
6.Linear Scleroderma Clinically Improved with Cyclosporine.
Su Jin OH ; Hyung Kwon PARK ; Young Gyun KIM ; Joung Soo KIM ; Hee Joon YU
Korean Journal of Dermatology 2016;54(6):487-489
No abstract available.
Cyclosporine*
;
Scleroderma, Localized*
7.Linear Scleroderma Clinically Improved with Cyclosporine.
Su Jin OH ; Hyung Kwon PARK ; Young Gyun KIM ; Joung Soo KIM ; Hee Joon YU
Korean Journal of Dermatology 2016;54(6):487-489
No abstract available.
Cyclosporine*
;
Scleroderma, Localized*
8.The Frequency of Metabolic Syndrome in Patients with Systemic Sclerosis.
Journal of Rheumatic Diseases 2012;19(6):305-306
No abstract available.
Humans
;
Scleroderma, Systemic
9.The pattern of antinuclear antibody and the positive rate of anti-Scl-70 in systemic sclerosis.
Korean Journal of Medicine 2000;58(3):340-341
No abstract available.
Antibodies, Antinuclear*
;
Scleroderma, Systemic*
10.A Case of a Bitemporal Atrophic Scar induced by Morphea, and treated by Autologous Fat Transplantation.
Hyung Su KIM ; Young Joon CHO ; Sang Eun MOON
Korean Journal of Dermatology 2005;43(9):1257-1259
A contour change induced by a subcutaneous depleting disorder such as lupus or morphea can be corrected by filling the defect with an artificial or natural materials of the types of fillers, autologous fat is popularly utilized for volumetric correction. Autologus fat has many advantages, such as easy harvesting, free volume, and non-immunogenicity. Herein, we report a case who of a bilateral atrophic scar on the temple area induced by morphea which was successfully treated by autologous fat transplantation.
Cicatrix*
;
Scleroderma, Localized*